Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002081016 | SCV002372536 | likely benign | not provided | 2024-05-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005032157 | SCV005662356 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-05-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003893233 | SCV004716447 | likely benign | FAT4-related disorder | 2021-12-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |